ISO 15189:2022 - Medical Laboratories - Requirements for Quality and Competence Free Practice Test — 30 Questions

Question 1

A medical laboratory receives a request for a specific biochemical assay accompanied by a blood sample. Upon visual inspection, the phlebotomist notes that the sample appears to have been collected into an incorrect anticoagulant tube, which is not validated for the requested assay. The sample also exhibits signs of hemolysis. Considering the laboratory\'s commitment to quality and the requirements of ISO 15189:2022, what is the most appropriate immediate action to ensure the integrity of the testing process and patient safety?

Accepted Answer

Reject the sample, document the reasons for rejection (incorrect anticoagulant and hemolysis), and inform the requesting healthcare professional.

Question 2

A medical laboratory, accredited under ISO 15189:2022, identifies a critical value for a patient\'s activated partial thromboplastin time (aPTT) indicating a high risk of bleeding. The designated laboratory personnel attempt to contact the requesting physician using the number provided on the requisition form. However, the number is no longer in service, and the physician does not receive the critical result notification for several hours, leading to a delay in appropriate patient management. Considering the laboratory\'s obligation to ensure the accuracy and timeliness of reporting, what is the most appropriate corrective action to prevent recurrence?

Accepted Answer

Implement a mandatory procedure for verifying patient contact information at the point of sample collection and establish a protocol for multiple, documented communication attempts for critical results, including escalation to a supervisor if initial attempts fail.

Question 3

A medical laboratory receives a batch of a novel, uncertified reference material intended for the calibration of a critical diagnostic assay. The supplier provides a basic datasheet but no certificate of analysis or explicit statement of traceability to national or international metrological standards. The laboratory\'s quality manager is tasked with determining the appropriate course of action to ensure compliance with ISO 15189:2022 requirements for metrological traceability. What is the most appropriate step to take in this situation?

Accepted Answer

Conduct a comprehensive internal validation study to characterize the reference material, establish its stability, homogeneity, and the metrological traceability of its assigned value to higher-order standards or reference methods, and document these findings.

Question 4

A medical laboratory is transitioning to a new automated immunoassay analyzer for a critical diagnostic test. This transition involves a new instrument platform and a new reagent kit from a different manufacturer. To ensure the continued reliability and accuracy of patient results generated by this new system, what is the most crucial step the laboratory must undertake prior to its routine clinical implementation?

Accepted Answer

Conduct a comprehensive analytical verification of the new analyzer and reagent system to confirm its performance characteristics meet established criteria for accuracy, precision, and analytical specificity.

Question 5

When a medical laboratory contracts with an external healthcare facility for the collection of biological samples intended for analysis, what is the laboratory\'s primary obligation under ISO 15189:2022 concerning the pre-analytical phase performed by the external facility?

Accepted Answer

To establish and maintain documented procedures that ensure the pre-analytical processes performed by the external facility meet the laboratory's quality requirements and to monitor compliance.

Question 6

A medical laboratory participating in an external quality assessment (EQA) scheme for a specific biochemical marker receives an unsatisfactory performance report for the latest proficiency testing event. The laboratory\'s internal quality control data for the same period shows no significant deviations. Considering the principles outlined in ISO 15189:2022 regarding the management of non-conforming work and the assurance of result validity, what is the most appropriate immediate course of action to validate the laboratory\'s analytical system for this marker?

Accepted Answer

Re-enter the EQA scheme for the specific analyte and demonstrate satisfactory performance.

Question 7

A medical laboratory, accredited to ISO 15189:2022, receives a patient sample for a complex diagnostic assay. Several days later, an unexpected and potentially critical result is flagged for review, necessitating a potential re-analysis or further investigation using the original sample. However, the laboratory\'s sample management system indicates that the sample has already been disposed of according to routine waste management protocols, as there was no specific instruction to retain it beyond the standard turnaround time for the initial test. What is the most appropriate immediate action for the laboratory director to take in response to this situation, considering the standard\'s emphasis on sample integrity and traceability?

Accepted Answer

Initiate a formal investigation into the sample handling and disposal procedures, identifying the root cause of the premature disposal and implementing corrective actions to prevent future occurrences.

Question 8

Consider a scenario at the Central City Medical Laboratory where a sample for a routine coagulation profile arrives from a remote clinic. Upon visual inspection at the reception desk, the technologist notes that the plasma appears significantly haemolysed, a condition that is known to interfere with the accuracy of several assays within the requested profile. The laboratory has established internal quality indicators for sample acceptability, including visual haemolysis levels. According to the principles outlined in ISO 15189:2022 for managing pre-examination variables, what is the most appropriate course of action for the laboratory in this situation to maintain the quality and competence of its services?

Accepted Answer

Reject the sample, document the reason for rejection (significant haemolysis), and request a new sample from the requesting clinic.

Question 9

A medical laboratory performing advanced molecular diagnostics discovers that a critical enzyme-based reagent, essential for a quantitative polymerase chain reaction (qPCR) assay, was inadvertently used for two weeks after its stated expiry date. The laboratory director is reviewing the incident to determine the appropriate course of action and to prevent future occurrences. Considering the principles of ISO 15189:2022, what is the most critical immediate step the laboratory must take regarding the patient results generated using this reagent?

Accepted Answer

Immediately cease the use of the reagent and initiate a thorough investigation into the circumstances of its continued use, including a review of patient results generated during the period of expiry.

Question 10

A medical laboratory receives a blood sample for urgent genomic sequencing. The sample, collected from a patient in a remote rural clinic, was transported via a standard courier service. Upon arrival, the sample container shows condensation on the inside, indicating it may have been exposed to temperatures outside the recommended range for nucleic acid stability during transit. The laboratory\'s standard operating procedure for sample reception mandates visual inspection for integrity and confirmation of correct labeling.

What is the most appropriate course of action for the laboratory, considering the potential impact on the genomic analysis and the requirements of ISO 15189:2022 regarding pre-examination processes?

Accepted Answer

Reject the sample due to potential compromise of nucleic acid integrity and inform the requesting clinician of the reason for rejection.

Question 11

A medical laboratory receives a biological sample for a requested biochemical assay. Upon initial inspection, the phlebotomist\'s handwritten notes on the requisition form indicate the patient\'s date of birth as 1975-03-15, but the barcode label affixed to the sample tube clearly displays the patient\'s date of birth as 1975-03-25. All other identifying information, including the patient\'s name and medical record number, matches between the requisition and the sample label. Considering the requirements of ISO 15189:2022 regarding the pre-examination phase, what is the most appropriate immediate action the laboratory should take?

Accepted Answer

Reject the sample and notify the requesting healthcare provider of the discrepancy to obtain clarification and a corrected requisition.

Question 12

A medical laboratory receives a blood sample for a patient scheduled for emergency surgery. Upon receipt, the laboratory technician notices that the patient\'s name and date of birth on the sample tube are partially smudged due to condensation, rendering them difficult to read definitively. The requesting physician\'s notes confirm the urgency and the tests required. What is the most appropriate course of action for the laboratory\'s quality manager to ensure compliance with ISO 15189:2022 regarding sample integrity and patient identification in the pre-examination phase?

Accepted Answer

Reject the sample due to compromised patient identification and initiate the process for a new sample collection.

Question 13

A medical laboratory is integrating a novel assay for quantifying a specific biomarker into its routine workflow. Prior to patient reporting, the laboratory has successfully implemented internal quality control (IQC) measures and is enrolled in relevant external quality assessment (EQA) programs for this assay. To ensure the reliability and appropriateness of this new analytical method for its intended clinical applications, what is the fundamental requirement stipulated by ISO 15189:2022 for the laboratory to undertake before commencing routine patient testing with this procedure?

Accepted Answer

Verification of the analytical procedure's performance characteristics against established criteria.

Question 14

A medical laboratory participating in an external quality assessment (EQA) scheme for a specific biochemical assay receives a failing score for the latest assessment cycle. The laboratory has a robust internal quality control system, and all internal QC data for the period appear within acceptable limits. However, the EQA failure indicates a potential issue with the analytical process that might have affected patient results. What is the most appropriate course of action for the laboratory director to ensure compliance with ISO 15189:2022 and patient safety?

Accepted Answer

Initiate a comprehensive investigation into the analytical system, re-evaluate all patient results reported during the period of the EQA failure, and implement necessary corrective actions based on the investigation findings.

Question 15

During an internal quality audit at the \"Aethelred Diagnostics\" facility, it was discovered that while all incoming patient samples were initially identified and logged against the accompanying requisition forms, the subsequent stages of sample processing, aliquotting, and storage did not consistently involve a documented secondary verification of the sample\'s identity and the requested examinations against the patient\'s demographic data. This procedural gap was noted as a potential risk to the integrity of the testing process. Considering the principles of quality management and traceability mandated by ISO 15189:2022, what is the most critical corrective action to address this identified deficiency?

Accepted Answer

Implement a formal, documented procedure for re-verifying sample identity and associated test requests at key stages of processing and storage.

Question 16

A medical laboratory is performing a novel assay for a rare biomarker. The only available reference material for this assay is a secondary reference material, which has been calibrated against a primary reference material by a different accredited laboratory. However, the calibration interval for this secondary reference material has recently expired, and the primary reference material is no longer available for recalibration. To maintain the validity of patient results for this assay, what is the most appropriate course of action for the laboratory, in accordance with ISO 15189:2022 requirements for traceability and measurement uncertainty?

Accepted Answer

Conduct a comprehensive validation study to establish the traceability and metrological traceability of the secondary reference material to recognized national or international standards, documenting the methodology and results.

Question 17

A medical laboratory accredited to ISO 15189:2022 has a critical need to outsource a specialized immunoassay test due to equipment failure. The laboratory director identifies a nearby accredited laboratory that offers this specific test. What is the primary responsibility of the originating laboratory in this scenario to maintain compliance with the standard?

Accepted Answer

Establish a formal agreement with the external laboratory, ensuring it meets equivalent quality and competence standards, and retain ultimate responsibility for the reported results.

Question 18

Consider a scenario where a medical laboratory is implementing a new Laboratory Information System (LIS) to manage patient data, test results, and quality control information. The laboratory director is seeking to ensure full compliance with ISO 15189:2022 requirements for information management. Which of the following actions best demonstrates adherence to the standard\'s stipulations regarding the verification and validation of such systems before their routine operational use?

Accepted Answer

Conducting a comprehensive, documented validation process that includes defining acceptance criteria, executing test scripts covering all critical functionalities, and obtaining formal sign-off on the system's performance and suitability for intended use.

Question 19

A medical laboratory is transitioning to a new automated immunoassay analyzer for a critical diagnostic test. This transition involves a complete change in the underlying detection technology and reagent system. Prior to routine patient testing, what is the most crucial step the laboratory must undertake to ensure the continued accuracy and reliability of patient results, as stipulated by quality management principles for analytical procedures?

Accepted Answer

Conduct a comprehensive analytical validation of the new analyzer and its associated reagents, demonstrating its performance characteristics against established criteria and comparing results with the previous method where appropriate.

Question 20

A medical laboratory, adhering to ISO 15189:2022, discovers during a routine internal audit that a batch of critical reagents used for a specific immunoassay was inadvertently utilized a day after its documented expiry date. This batch was used for testing multiple patient samples processed over that period. The laboratory director needs to implement the appropriate response as per the standard\'s requirements for managing non-conforming work. Which of the following actions represents the most immediate and compliant first step in addressing this situation?

Accepted Answer

Immediately quarantine all patient reports generated using the implicated reagent batch and the corresponding samples, and initiate a root cause analysis to determine the extent of the impact and necessary corrective actions.

Question 21

A medical laboratory, accredited under ISO 15189:2022, is undergoing an external audit. The auditors are reviewing the laboratory\'s procedures for ensuring the accuracy and comparability of its quantitative test results. They specifically inquire about how the laboratory guarantees that its reported values for a critical analyte, such as serum creatinine, are traceable to recognized standards. Which of the following best describes the fundamental requirement the laboratory must demonstrate to satisfy this aspect of the audit?

Accepted Answer

The laboratory must maintain a documented system that establishes an unbroken chain of comparisons from its measurement results to appropriate national or international reference standards, including documented evidence of calibration, verification, and associated uncertainties.

Question 22

A critical patient sample, vital for an immediate life-saving treatment decision, is processed, and the preliminary result indicates a severe anomaly. Upon further review, it is discovered that the sample was not stored at the required temperature during transport to the laboratory, potentially compromising its integrity. What is the most appropriate immediate and subsequent action for the medical laboratory, according to the principles of ISO 15189:2022, to address this critical pre-examination failure?

Accepted Answer

Immediately initiate a thorough investigation into the pre-examination process, focusing on the transport and storage conditions, document the deviation, and communicate the potential impact on the result to the requesting clinician, while simultaneously implementing corrective actions to prevent recurrence.

Question 23

A medical laboratory in a region with a newly enacted national regulation mandating the use of validated analytical methods for all diagnostic tests decides to implement a novel assay for quantifying vitamin D levels in patient serum. Prior to routine use, what fundamental steps must the laboratory undertake to ensure compliance with the principles of ISO 15189:2022 and the new regulatory framework regarding the analytical performance of this new method?

Accepted Answer

Conduct a comprehensive analytical validation study to establish the method's accuracy, precision, linearity, and analytical sensitivity, and verify the appropriateness of reference intervals for the local patient population.

Question 24

A medical laboratory receives a blood sample for routine chemistry analysis. Upon initial verification, the phlebotomist\'s handwritten label on the sample tube clearly indicates the patient\'s name as \"Ananya Sharma,\" but the accompanying electronic request form bears the name \"Anjali Sharma\" and a different patient identification number. The laboratory\'s internal quality policy mandates strict adherence to patient identification protocols. Which of the following actions best aligns with the requirements of ISO 15189:2022 regarding pre-examination processes and patient safety?

Accepted Answer

Halt all analytical procedures for the sample and immediately contact the requesting clinician to resolve the identification discrepancy before proceeding.

Question 25

A medical laboratory is implementing a new immunoassay for a critical analyte. The assay utilizes a commercially available kit that includes an internal reference standard. The laboratory director is reviewing the documentation to ensure compliance with ISO 15189:2022, particularly regarding metrological traceability. What is the most crucial step the laboratory must undertake to verify that the results generated using this kit are metrologically traceable?

Accepted Answer

Obtain and scrutinize the manufacturer's documentation confirming the metrological traceability of the internal reference standard to national or international standards.

Question 26

A medical laboratory, following ISO 15189:2022 guidelines, encounters an unexpected equipment malfunction with a critical analytical instrument. The standard calibration procedure cannot be immediately performed due to a supply chain delay for a specific reagent. The laboratory director considers proceeding with patient testing using the instrument after performing a limited verification. Which of the following actions best demonstrates adherence to the standard\'s principles for managing such deviations and ensuring result integrity?

Accepted Answer

Documenting the deviation, conducting a risk assessment on the potential impact on result validity, performing a limited verification of the instrument's performance against established criteria, and implementing corrective actions to address any identified issues before reporting results.

Question 27

A medical laboratory, accredited under ISO 15189:2022, receives a biological specimen for a complex diagnostic assay. During the initial sample accessioning, a crucial visual integrity check, mandated by the laboratory\'s standard operating procedure (SOP) for this specific assay, was inadvertently skipped by a technician due to a high workload. The sample proceeded to the examination phase. Upon discovery of this omission during a subsequent internal audit, what is the most critical immediate action the laboratory director must ensure is taken to uphold the standard\'s requirements for quality and patient safety?

Accepted Answer

Promptly inform the requesting healthcare professional about the missed pre-examination step and its potential implications for the reported results.

Question 28

Consider a scenario where a medical laboratory is undergoing an accreditation assessment against ISO 15189:2022. During the review of external quality assessment (EQA) participation, the assessor inquires about the laboratory\'s procedures for ensuring the traceability of EQA results to the analytical systems and personnel involved in routine patient testing. Which of the following practices best demonstrates adherence to the standard\'s requirements for data integrity and traceability in this context?

Accepted Answer

Maintaining a detailed log that cross-references EQA sample identifiers with the specific patient sample identifiers and analytical run numbers processed concurrently, along with the assigned analyst and instrument used for each.

Question 29

A medical laboratory receives a blood sample for urgent biochemical analysis. The accompanying requisition form is partially completed, correctly identifying the requested tests and the referring physician, but it omits the patient\'s date of birth. The laboratory\'s internal quality policy, aligned with ISO 15189:2022, mandates complete patient identification for all incoming specimens. Considering the laboratory\'s obligations under the standard regarding pre-examination processes and patient safety, what is the most appropriate immediate action for the laboratory to take?

Accepted Answer

Reject the sample and inform the requesting clinician of the missing critical identification information, requesting clarification or a new sample.

Question 30

A medical laboratory decides to implement a commercially available, pre-validated analytical method for quantifying a novel biomarker. The manufacturer provides comprehensive validation data, including linearity, LoD, LoQ, precision, and interference studies. However, the laboratory\'s standard operating procedure for introducing new methods mandates a distinct verification process. What are the essential performance characteristics that the laboratory must verify to ensure the method\'s suitability for its intended use within its specific operational environment, as per ISO 15189:2022 guidelines?

Accepted Answer

Accuracy, precision (repeatability and intermediate precision), linearity, range, limit of detection, limit of quantitation, specificity, and reference interval

ISO 15189:2022 - Medical Laboratories - Requirements for Quality and Competence Free Practice Test — 30 Questions

A lot more is already mapped out

About the ISO 15189:2022 - Medical Laboratories - Requirements for Quality and Competence Certification